with Clinical Manifestations
暂无分享,去创建一个
Richard | M. M. K. Kate Hanneman | MD Suhny Abbara | M. M. Amer M. Johri | MD a Prabhakar Rajiah | M. M. B. Jacobo Kirsch | MD c Michael A. Bolen | M. M. Juan C. Batlle | MD e KJ Brown | MD f Christopher J. Francois | MD g Mauricio S. Galizia | MD i Joao R. Inacio | MD MSc Daniel C. Lee | MD l Satinder P. Singh | MD m Todd C. Villines | MD n Samuel Wann | MD o Stefan L. Zimmerman | M. M. H. Kate Hanneman | Richard
[1] K. Ellenbogen,et al. Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[2] Daniel S. Cormican,et al. Ultrasonic Enhancing Agents for the Cardiothoracic Anesthesiologist: A Focused Review of the 2018 American Society of Echocardiography Guidelines Update. , 2019, Journal of cardiothoracic and vascular anesthesia.
[3] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.
[4] J. Leipsic,et al. ACR Appropriateness Criteria® Suspected New-Onset and Known Nonacute Heart Failure. , 2018, Journal of the American College of Radiology : JACR.
[5] J. Moon,et al. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease , 2018, Heart.
[6] R. Manka,et al. Approximation of the Incidence of Myocarditis by Systematic Screening With Cardiac Magnetic Resonance Imaging. , 2018, JACC. Heart failure.
[7] Jeroen J. Bax,et al. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management , 2018, European heart journal.
[8] Jeroen J. Bax,et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology , 2018, European heart journal.
[9] Harald Becher,et al. Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[10] Lazaro E Hernandez. Myocardial stress perfusion magnetic resonance in children with hypertrophic cardiomyopathy , 2018, Cardiology in the Young.
[11] A. Henning,et al. Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy , 2017, Circulation.
[12] D. Gohn,et al. Real-World Evaluation of Magnetic Resonance Imaging in Patients With a Magnetic Resonance Imaging Conditional Pacemaker System: Results of 4-Year Prospective Follow-Up in 2,629 Patients. , 2017, JACC. Clinical electrophysiology.
[13] J. Zamorano,et al. Left Ventricular Global Strain Analysis by Two‐Dimensional Speckle‐Tracking Echocardiography: The Learning Curve , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[14] R. Manka,et al. Cardiac Magnetic Resonance Imaging in Myocarditis Reveals Persistent Disease Activity Despite Normalization of Cardiac Enzymes and Inflammatory Parameters at 3-Month Follow-Up , 2017, Circulation. Heart failure.
[15] Richard B. Thompson,et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.
[16] P. Rajiah,et al. Computed tomography of cardiomyopathies. , 2017, Cardiovascular diagnosis and therapy.
[17] E. Braunwald,et al. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. , 2017, Circulation research.
[18] B. Maron,et al. Classification, Epidemiology, and Global Burden of Cardiomyopathies. , 2017, Circulation research.
[19] Birgitta K. Velthuis,et al. Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia/ cardiomyopathy: a multisoftware feasibility and clinical implementation study , 2017, Journal of Cardiovascular Magnetic Resonance.
[20] R. Herfkens,et al. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis , 2017, Clinical nuclear medicine.
[21] H. Heidbuchel,et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. , 2017, Heart rhythm.
[22] P. Thavendiranathan,et al. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies. , 2017, Revista espanola de cardiologia.
[23] Richard D. White,et al. ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin. , 2017, Journal of the American College of Radiology : JACR.
[24] E. Nagel,et al. T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis. , 2017, Radiology.
[25] N. Tamaki,et al. Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study , 2017, European Radiology.
[26] Jason C. Rubenstein,et al. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator , 2017, New England Journal of Medicine.
[27] M. Xie,et al. Incremental value of contrast echocardiography in the diagnosis of left ventricular noncompaction , 2016, Frontiers of Medicine.
[28] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[29] P. Rajiah,et al. Update on the Role of Cardiac Magnetic Resonance in Acquired Nonischemic Cardiomyopathies , 2016, Journal of thoracic imaging.
[30] K. Sliwa,et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy , 2016, European journal of heart failure.
[31] I. M. Pereira,et al. Analysis of Regional Left Ventricular Strain in Patients with Chagas Disease and Normal Left Ventricular Systolic Function. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[32] P. Rajiah,et al. Utility of late gadolinium enhancement in pediatric cardiac MRI , 2016, Pediatric Radiology.
[33] J. Moon,et al. Cardiac MRI evaluation of myocardial disease , 2016, Heart.
[34] Q. Fang,et al. Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis , 2016, BMC Cardiovascular Disorders.
[35] Stefan L. Zimmerman,et al. Right ventricular strain by MR quantitatively identifies regional dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy , 2016, Journal of magnetic resonance imaging : JMRI.
[36] D. Vargas,et al. Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.
[37] Thor Edvardsen,et al. Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia , 2016, European heart journal cardiovascular Imaging.
[38] P. Soman,et al. Radionuclide Imaging Applications in Cardiomyopathies and Heart Failure , 2016, Current Cardiology Reports.
[39] H. Lee,et al. Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging. , 2016, Radiology.
[40] Pawan K Gupta,et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. , 2015, Heart rhythm.
[41] C. Rochitte,et al. Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance , 2015, Journal of Cardiovascular Magnetic Resonance.
[42] S. Punwani,et al. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis , 2015, Journal of cardiovascular computed tomography.
[43] P. Kellman,et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2015, Circulation.
[44] N. Smedira,et al. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. , 2015, Circulation. Cardiovascular imaging.
[45] R. Underwood,et al. Cardiac sarcoidosis: diagnosis and management , 2015, Postgraduate Medical Journal.
[46] M. Maron. The role of cardiovascular magnetic resonance in sudden death risk stratification in hypertrophic cardiomyopathy. , 2015, Cardiac electrophysiology clinics.
[47] S. K. White,et al. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload , 2015, Journal of magnetic resonance imaging : JMRI.
[48] B. Wong,et al. Myocardial Fibrosis Burden Predicts Left Ventricular Ejection Fraction and Is Associated With Age and Steroid Treatment Duration in Duchenne Muscular Dystrophy , 2015, Journal of the American Heart Association.
[49] S. Gabriel,et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease , 2015, Nature Reviews Cardiology.
[50] A. Luciani,et al. Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study , 2015, European Radiology.
[51] S. K. White,et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance , 2014, Journal of Cardiovascular Magnetic Resonance.
[52] Martin Borggrefe,et al. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.
[53] J. Hanmer,et al. Cardiovascular magnetic resonance characterization of left ventricular non-compaction provides independent prognostic information in patients with incident heart failure or suspected cardiomyopathy , 2014, Journal of Cardiovascular Magnetic Resonance.
[54] G. Feuchtner,et al. Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: multidetector computed tomography versus magnetic resonance imaging. , 2014, European journal of radiology.
[55] Tevfik F Ismail,et al. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study , 2014, Journal of Cardiovascular Magnetic Resonance.
[56] V. Fuster,et al. The MOGE(S) classification of cardiomyopathy for clinicians. , 2014, Journal of the American College of Cardiology.
[57] D. Bluemke,et al. Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update , 2014, Journal of Cardiovascular Magnetic Resonance.
[58] Paaladinesh Thavendiranathan,et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. , 2014, Journal of the American College of Cardiology.
[59] E. Omerovic,et al. Takotsubo triggered by acute myocardial infarction: a common but overlooked syndrome? , 2014, Journal of geriatric cardiology : JGC.
[60] W. Shimizu,et al. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis , 2014, Heart.
[61] A. Nemes,et al. Left Ventricular Strain Reduction Is Not Confined to the Noncompacted Segments in Noncompaction Cardiomyopathy–Insights from the Three‐Dimensional Speckle Tracking Echocardiographic MAGYAR‐Path Study , 2014, Echocardiography.
[62] P. Matthews,et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis – a clinical study using myocardial T1-mapping and extracellular volume quantification , 2014, Journal of Cardiovascular Magnetic Resonance.
[63] Derliz Mereles,et al. Quantitative analysis of left ventricular strain using cardiac computed tomography. , 2014, European journal of radiology.
[64] L. Afonso,et al. Cardiac Magnetic Resonance Imaging in Peripartum Cardiomyopathy , 2014, The American journal of the medical sciences.
[65] L. Anderson,et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. , 2014, JACC. Cardiovascular imaging.
[66] Daniel B Ennis,et al. Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverter-defibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping. , 2014, Heart rhythm.
[67] K. Klingel,et al. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis , 2014, Journal of Cardiovascular Magnetic Resonance.
[68] W. Burchert,et al. Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients , 2014, The International Journal of Cardiovascular Imaging.
[69] Ashley M. Lee,et al. Defining Left Ventricular Noncompaction Using Cardiac Computed Tomography , 2014, Journal of thoracic imaging.
[70] S. Flamm,et al. Cardiac MRI in the Assessment of Cardiac Injury and Toxicity From Cancer Chemotherapy: A Systematic Review , 2013, Circulation. Cardiovascular imaging.
[71] Marmar Vaseghi,et al. Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices. , 2013, Radiology.
[72] M. Robson,et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.
[73] G. Gladish,et al. Cardiac complications of oncologic therapy. , 2013, Radiographics : a review publication of the Radiological Society of North America, Inc.
[74] Stefan Neubauer,et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.
[75] Katja Zeppenfeld,et al. Contrast-Enhanced MRI–Derived Scar Patterns and Associated Ventricular Tachycardias in Nonischemic Cardiomyopathy: Implications for the Ablation Strategy , 2013, Circulation. Arrhythmia and electrophysiology.
[76] W. Hundley,et al. Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR. , 2013, JACC. Cardiovascular imaging.
[77] D. Pennell,et al. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. , 2013, Circulation.
[78] A. Freeman,et al. Predictors of cardiac sarcoidosis using commonly available cardiac studies. , 2013, The American journal of cardiology.
[79] N. Hagiwara,et al. Utility of ECG-gated MDCT to differentiate patients with ARVC/D from patients with ventricular tachyarrhythmias. , 2013, Journal of cardiovascular computed tomography.
[80] G. Sanz,et al. Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. , 2013, International journal of cardiology.
[81] I. Rinta-Kiikka,et al. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer. , 2013, Journal of the American College of Cardiology.
[82] U. Kramer,et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.
[83] M. Robson,et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.
[84] Reza Razavi,et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[85] Xiaohai Ma,et al. Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography , 2013, European Radiology.
[86] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[87] W. Edwards,et al. Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation. , 2013, AJR. American journal of roentgenology.
[88] M. Friedrich,et al. Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols , 2013, The International Journal of Cardiovascular Imaging.
[89] J. Hoffmann,et al. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies , 2012, European Radiology.
[90] M. Robson,et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.
[91] James D. Thomas,et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis , 2012, Heart.
[92] Bernd Hamm,et al. Head-to-head comparison of left ventricular function assessment with 64-row computed tomography, biplane left cineventriculography, and both 2- and 3-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging as the reference standard. , 2012, Journal of the American College of Cardiology.
[93] D. Bluemke,et al. Trabeculated (non-compacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis , 2012, Journal of Cardiovascular Magnetic Resonance.
[94] T. Kristensen,et al. Accuracy of multi-slice computed tomography for measurement of left ventricular ejection fraction compared with cardiac magnetic resonance imaging and two-dimensional transthoracic echocardiography: a systematic review and meta-analysis. , 2012, European Journal of Radiology.
[95] C. Hasdemir,et al. Late Gadolinium Enhancement CMR in Patients with Tachycardia‐Induced Cardiomyopathy Caused by Idiopathic Ventricular Arrhythmias , 2012, Pacing and clinical electrophysiology : PACE.
[96] R. Cury,et al. Cardiac MR Imaging of Nonischemic Cardiomyopathies: Imaging Protocols and Spectra of Appearances. , 2012, Radiology.
[97] M. Maron,et al. Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy , 2012, Journal of Cardiovascular Magnetic Resonance.
[98] Robert A. deKemp,et al. The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience , 2012, The Journal of Nuclear Medicine.
[99] A. Sato,et al. The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy: serial analysis of cardiovascular magnetic resonance images , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[100] R. Dietz,et al. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging. , 2011, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[101] J. Fishman,et al. Takotsubo cardiomyopathy: utility of cardiac computed tomography angiography for acute diagnosis. , 2011, Journal of thoracic imaging.
[102] G. Schuler,et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.
[103] P. Rusconi,et al. Danon disease: characteristic late gadolinium enhancement pattern on cardiac magnetic resonance imaging , 2011, Cardiology in the Young.
[104] Vasken Dilsizian,et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomograph , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[105] Raymond J Kim,et al. Late Gadolinium Enhancement Magnetic Resonance Imaging in the Diagnosis and Prognosis of Endomyocardial Fibrosis Patients , 2011, Circulation. Cardiovascular imaging.
[106] J. Schulz-Menger,et al. Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis , 2011, European Radiology.
[107] Jeroen J. Bax,et al. Feasibility of diastolic function assessment with cardiac CT: feasibility study in comparison with tissue Doppler imaging. , 2011, JACC. Cardiovascular imaging.
[108] A. Ghandforoush,et al. Viability assessment by multidetector computed tomography in Takotsubo cardiomyopathy. , 2011, Journal of thoracic imaging.
[109] Eckart Fleck,et al. Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.
[110] David A Bluemke,et al. MRI of nonischemic cardiomyopathy. , 2010, AJR. American journal of roentgenology.
[111] K. Sliwa,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy , 2010, European journal of heart failure.
[112] J. Wansapura,et al. Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy. , 2010, The American journal of cardiology.
[113] Gilbert Habib,et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. , 2010, European heart journal.
[114] J. Seward,et al. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. , 2010, Journal of the American College of Cardiology.
[115] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.
[116] F. Thuny,et al. Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography. , 2010, Archives of cardiovascular diseases.
[117] M. Ishihara,et al. Prevalence of incidental coronary artery disease in tako-tsubo cardiomyopathy , 2009, Coronary artery disease.
[118] A. Del Maschio,et al. Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. , 2009, AJR. American journal of roentgenology.
[119] D. Pennell,et al. Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[120] Matthew W. Martinez,et al. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. , 2008, International journal of cardiology.
[121] M. Nishimura,et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[122] N. Kelekis,et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. , 2007, Arthritis and rheumatism.
[123] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[124] R. Cury,et al. Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. , 2007, AJR. American journal of roentgenology.
[125] Mario J. Garcia,et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy , 2007, Heart.
[126] D. Andreini,et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy. , 2007, Journal of the American College of Cardiology.
[127] J. Serfaty,et al. Diagnostic value of ECG-gated multidetector computed tomography in the early phase of suspected acute myocarditis. A preliminary comparative study with cardiac MRI , 2007, European Radiology.
[128] K. Klingel,et al. Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.
[129] R. Hruban,et al. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. , 2004, American heart journal.
[130] C H Lorenz,et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.
[131] D N Firmin,et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.
[132] F. Follath,et al. Nonischemic heart failure: epidemiology, pathophysiology, and progression of disease. , 1999, Journal of cardiovascular pharmacology.
[133] A. Tajik,et al. Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. , 1996, Circulation.
[134] C. Morillo,et al. Recommendations for Multimodality Cardiac Imaging in Patients with Chagas Disease: A Report from the American Society of Echocardiography in Collaboration With the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[135] R. Coulden,et al. Cardiac magnetic resonance assessment of takotsubo cardiomyopathy. , 2016, Clinical radiology.
[136] E. Nagel,et al. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.
[137] S. Kaste,et al. ACR – NASCI – SIR – SPR PRACTICE PARAMETER FOR THE PERFORMANCE AND INTERPRETATION OF BODY COMPUTED TOMOGRAPHY ANGIOGRAPHY , 2016 .
[138] Jonathan R. Weir-McCall,et al. Left Ventricular Noncompaction Anatomical Phenotype or Distinct Cardiomyopathy ? , 2016 .
[139] Chagas disease in Latin America: an epidemiological update based on 2010 estimates. , 2015, Releve epidemiologique hebdomadaire.
[140] J. Stockman,et al. A Prospective Evaluation of a Protocol for Magnetic Resonance Imaging of Patients With Implanted Cardiac Devices , 2013 .
[141] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[142] H. Sakuma,et al. Prevalence and signal characteristics of late gadolinium enhancement on contrast-enhanced magnetic resonance imaging in patients with takotsubo cardiomyopathy. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[143] P. Sanders,et al. Cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis: presenting as ventricular tachycardia. , 2011, Texas Heart Institute journal.
[144] S. Raman,et al. Advances in Cardiovascular Imaging Cardiac Involvement in Patients With Muscular Dystrophies Magnetic Resonance Imaging Phenotype and Genotypic Considerations , 2011 .
[145] P. Nihoyannopoulos,et al. Restrictive cardiomyopathies. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[146] J. Bogaert,et al. Nonischemic Myocardial Disease , 2005 .
[147] H. Fleming. Cardiac sarcoidosis. , 1986, Clinics in dermatology.